Catalyst Biosciences, Inc.

NasdaqCM:CBIO Stock Report

Market Cap: US$19.4m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Catalyst Biosciences Future Growth

Future criteria checks 0/6

Catalyst Biosciences is forecast to grow earnings at 75.6% per annum. EPS is expected to grow by 61.4% per annum.

Key information

75.6%

Earnings growth rate

61.4%

EPS growth rate

Biotechs earnings growth24.0%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

Low

Last updated15 Aug 2023

Recent future growth updates

Recent updates

Catalyst Biosciences declares special one-time dividend of $1.43

Aug 25

Catalyst Biosciences: Shareholders Should Reap Benefits From Owning The Stock

Aug 15

Catalyst Biosciences plans to distribute $65M cash to stockholders

Jun 29

Companies Like Catalyst Biosciences (NASDAQ:CBIO) Could Be Quite Risky

Jan 11
Companies Like Catalyst Biosciences (NASDAQ:CBIO) Could Be Quite Risky

Circling Back On Catalyst Biosciences

Dec 08

Shareholders May Not Be So Generous With Catalyst Biosciences, Inc.'s (NASDAQ:CBIO) CEO Compensation And Here's Why

Jun 03
Shareholders May Not Be So Generous With Catalyst Biosciences, Inc.'s (NASDAQ:CBIO) CEO Compensation And Here's Why

Catalyst Biosciences (NASDAQ:CBIO) Will Have To Spend Its Cash Wisely

May 18
Catalyst Biosciences (NASDAQ:CBIO) Will Have To Spend Its Cash Wisely

Would Shareholders Who Purchased Catalyst Biosciences' (NASDAQ:CBIO) Stock Five Years Be Happy With The Share price Today?

Mar 09
Would Shareholders Who Purchased Catalyst Biosciences' (NASDAQ:CBIO) Stock Five Years Be Happy With The Share price Today?

We're Hopeful That Catalyst Biosciences (NASDAQ:CBIO) Will Use Its Cash Wisely

Feb 01
We're Hopeful That Catalyst Biosciences (NASDAQ:CBIO) Will Use Its Cash Wisely

Do Institutions Own Catalyst Biosciences, Inc. (NASDAQ:CBIO) Shares?

Dec 28
Do Institutions Own Catalyst Biosciences, Inc. (NASDAQ:CBIO) Shares?

What We Learned About Catalyst Biosciences' (NASDAQ:CBIO) CEO Pay

Dec 02
What We Learned About Catalyst Biosciences' (NASDAQ:CBIO) CEO Pay

Earnings and Revenue Growth Forecasts

NasdaqCM:CBIO - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025N/A-10N/A1
12/31/2024N/A-10N/A1
12/31/2023N/A-6N/AN/A1
9/30/2023N/A-44-13-13N/A
6/30/2023N/A-48-17-17N/A
3/31/2023N/A7-27-27N/A
12/31/20221-8-33-33N/A
9/30/2022312-49-49N/A
6/30/20226-8-64-64N/A
3/31/20227-80-72-71N/A
12/31/20217-88-85-84N/A
9/30/20217-87-89-88N/A
6/30/20216-77-80-80N/A
3/31/20216-75-75-75N/A
12/31/202021-56-55-55N/A
9/30/202019-51-41-41N/A
6/30/202018-48-37-37N/A
3/31/202016-44-34-33N/A
12/31/2019N/A-55-44-44N/A
9/30/2019N/A-52-45-45N/A
6/30/2019N/A-47-43-42N/A
3/31/2019N/A-40-39-38N/A
12/31/20180-30-29-29N/A
9/30/20180-25-26-26N/A
6/30/20181-23-24-24N/A
3/31/20181-26-21-21N/A
12/31/20171-26-20-20N/A
9/30/20171-24-19-19N/A
6/30/20171-22N/A-19N/A
3/31/20171-17N/A-18N/A
12/31/20160-17N/A-18N/A
9/30/20160-18N/A-19N/A
6/30/20160-19N/A-23N/A
3/31/20161-15N/A-21N/A
12/31/20152-15N/A-19N/A
9/30/20152-11N/A-16N/A
6/30/20153-7N/A-7N/A
3/31/20152-8N/A-8N/A
12/31/20142-7N/A-6N/A
12/31/20131-10N/A-6N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CBIO is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CBIO is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CBIO is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: Insufficient data to determine if CBIO's revenue is forecast to grow faster than the US market.

High Growth Revenue: CBIO is forecast to have no revenue next year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if CBIO's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/10/31 03:26
End of Day Share Price 2023/10/30 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Catalyst Biosciences, Inc. is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
George ZavoicoB. Riley Securities, Inc.
Gbolahan Amusa BenzChardan Capital Markets, LLC
Kevin DeGeeterLadenburg Thalmann & Company